Hauner, H
[Managing the obese patient]
Med Klin (Munich)
2003
98
10
569-76

Hauner, H
[A drug help in reducing? Risk profile decides whether and how]
MMW Fortschr Med
2003
145
21
60

Frey, UH;Bachmann, HS;Hauner, H;Siffert, W
The G(S alpha) gene is a pharmacogenetic marker for weight reduction under therapy with sibutramine
Naunyn Schmiedebergs Arch Pharmacol
2003
367 Suppl.
R117-R117

Hauner, H;n.a.
Management of the obese patient
Med Klin
2003
98
10
569-576

van Harmelen, V;Skurk, T;Röhrig, K;Lee, YM;Halbleib, M;Aprath-Husmann, I;Hauner, H
Effect of BMI and age on adipose tissue cellularity and differentiation capacity in women
Int J Obes Relat Metab Disord
2003
27
8
889-895

Budde, P;Appel, A;Neitz, S;Schulte, I;Tammen, H;Skurk, T;Hauner, H;Rose, H;Reiter, R
Thiazolidinedione-regulated polypeptides in the supernatant of human and rodent adipocytes.
Diabetologia
2003
46 Suppl.
A287-A287

Dietze, D;Koenen, M;Roerig, K;Ritzeler, O;Tennagels, N;Hauner, H;Eckel, J
IkappaB kinase is involved in the paracrine crosstalk between human fat and muscle cells
Diabetes
2003
52 Suppl.
A286-A286

Hauner, H;n.a.
Is obesity a disease?
Chir Gastroenterol
2003
19
1
8-11

Hauner, H;Köster, I;von Ferber, L
[Outpatient care of patients with diabetes mellitus in 2001. Analysis of a health insurance sample of the AOK in Hesse/KV in Hesse]
Dtsch Med Wochenschr
2003
128
50
2638-43

Hauner, H;Maxion-Bergemann, S;Muller, E;Schulz, M;Huppertz, E;Bergemann, R
[Disease management program (DMP) diabetes mellitus: simulation of therapeutic results of different guidelines. A new diabetes mellitus model (DMM)]
Dtsch Med Wochenschr
2003
128
21
1167-72